Annual FCF:
$17.83B-$4.23B(-19.17%)Summary
- As of today, ABBV annual free cash flow is $17.83 billion, with the most recent change of -$4.23 billion (-19.17%) on December 31, 2024.
- During the last 3 years, ABBV annual free cash flow has fallen by -$4.16 billion (-18.91%).
- ABBV annual free cash flow is now -26.46% below its all-time high of $24.25 billion, reached on December 31, 2022.
Performance
ABBV Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
N/ASummary
- ABBV quarterly free cash flow is not available.
Performance
ABBV Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
TTM FCF:
N/ASummary
- ABBV TTM free cash flow is not available.
Performance
ABBV TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
ABBV Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -19.2% | - | - |
| 3Y3 Years | -18.9% | - | - |
| 5Y5 Years | +39.6% | - | - |
ABBV Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -26.5% | at low | ||||
| 5Y | 5-Year | -26.5% | +39.6% | ||||
| All-Time | All-Time | -26.5% | +507.1% |
ABBV Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $4.88B(+248.9%) | $18.24B(+18.6%) |
| Mar 2025 | - | $1.40B(-79.3%) | $15.38B(-13.7%) |
| Dec 2024 | $17.83B(-19.2%) | $6.76B(+30.0%) | $17.83B(+14.4%) |
| Sep 2024 | - | $5.20B(+156.1%) | $15.59B(-12.2%) |
| Jun 2024 | - | $2.03B(-47.2%) | $17.74B(-18.8%) |
| Mar 2024 | - | $3.85B(-14.7%) | $21.85B(-0.8%) |
| Dec 2023 | $22.06B(-9.0%) | $4.51B(-38.7%) | $22.02B(-10.9%) |
| Sep 2023 | - | $7.36B(+19.8%) | $24.73B(-0.3%) |
| Jun 2023 | - | $6.14B(+52.8%) | $24.80B(+5.4%) |
| Mar 2023 | - | $4.02B(-44.3%) | $23.52B(-3.0%) |
| Dec 2022 | $24.25B(+10.3%) | $7.21B(-2.8%) | $24.25B(+10.6%) |
| Sep 2022 | - | $7.42B(+52.7%) | $21.92B(-1.3%) |
| Jun 2022 | - | $4.86B(+2.4%) | $22.21B(+0.8%) |
| Mar 2022 | - | $4.75B(-2.9%) | $22.05B(+0.3%) |
| Dec 2021 | $21.99B(+31.0%) | $4.89B(-36.7%) | $21.99B(+7.4%) |
| Sep 2021 | - | $7.72B(+64.4%) | $20.48B(+11.5%) |
| Jun 2021 | - | $4.70B(+0.1%) | $18.37B(+10.7%) |
| Mar 2021 | - | $4.69B(+38.9%) | $16.59B(+6.4%) |
| Dec 2020 | $16.79B(+31.5%) | $3.38B(-39.9%) | $15.59B(+1.7%) |
| Sep 2020 | - | $5.61B(+92.8%) | $15.33B(+7.3%) |
| Jun 2020 | - | $2.91B(-21.1%) | $14.29B(+5.4%) |
| Mar 2020 | - | $3.69B(+18.6%) | $13.55B(+6.1%) |
| Dec 2019 | $12.77B(-0.1%) | $3.11B(-31.9%) | $12.77B(-1.2%) |
| Sep 2019 | - | $4.57B(+109.9%) | $12.93B(+2.6%) |
| Jun 2019 | - | $2.18B(-25.2%) | $12.60B(-4.4%) |
| Mar 2019 | - | $2.91B(-11.0%) | $13.17B(+3.0%) |
| Dec 2018 | $12.79B(+35.6%) | $3.27B(-22.9%) | $12.79B(+7.3%) |
| Sep 2018 | - | $4.24B(+54.1%) | $11.92B(+10.1%) |
| Jun 2018 | - | $2.75B(+8.9%) | $10.82B(+8.8%) |
| Mar 2018 | - | $2.53B(+5.2%) | $9.95B(+5.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | $9.43B(+43.7%) | $2.40B(-23.6%) | $9.43B(+11.5%) |
| Sep 2017 | - | $3.15B(+67.6%) | $8.46B(+27.1%) |
| Jun 2017 | - | $1.88B(-6.5%) | $6.65B(+1.4%) |
| Mar 2017 | - | $2.01B(+40.6%) | $6.56B(0.0%) |
| Dec 2016 | $6.56B(-6.3%) | $1.43B(+6.4%) | $6.56B(-5.6%) |
| Sep 2016 | - | $1.34B(-25.0%) | $6.95B(-9.0%) |
| Jun 2016 | - | $1.79B(-11.0%) | $7.64B(+0.9%) |
| Mar 2016 | - | $2.01B(+10.4%) | $7.57B(+8.1%) |
| Dec 2015 | $7.00B(+138.4%) | $1.82B(-10.4%) | $7.00B(+57.2%) |
| Sep 2015 | - | $2.03B(+18.1%) | $4.45B(+10.5%) |
| Jun 2015 | - | $1.72B(+19.2%) | $4.03B(+3.7%) |
| Mar 2015 | - | $1.44B(+297.0%) | $3.89B(+32.4%) |
| Dec 2014 | $2.94B(-49.2%) | -$731.00M(-145.5%) | $2.94B(-38.3%) |
| Sep 2014 | - | $1.61B(+2.0%) | $4.76B(-1.2%) |
| Jun 2014 | - | $1.57B(+223.4%) | $4.82B(-6.6%) |
| Mar 2014 | - | $487.00M(-55.5%) | $5.16B(-10.6%) |
| Dec 2013 | $5.78B(-3.9%) | $1.09B(-34.3%) | $5.78B(+4.5%) |
| Sep 2013 | - | $1.67B(-13.2%) | $5.53B(-9.8%) |
| Jun 2013 | - | $1.92B(+74.5%) | $6.13B(+7.9%) |
| Mar 2013 | - | $1.10B(+29.8%) | $5.68B(-5.5%) |
| Dec 2012 | $6.01B(+2.1%) | $846.99M(-62.6%) | $6.01B(-1.6%) |
| Sep 2012 | - | $2.27B(+54.4%) | $6.11B(+10.1%) |
| Jun 2012 | - | $1.47B(+2.5%) | $5.55B(-9.6%) |
| Mar 2012 | - | $1.43B(+51.6%) | $6.14B(+4.2%) |
| Dec 2011 | $5.89B(+30.1%) | $944.35M(-44.7%) | $5.89B(+19.1%) |
| Sep 2011 | - | $1.71B(-17.0%) | $4.95B(+52.6%) |
| Jun 2011 | - | $2.06B(+73.5%) | $3.24B(+173.5%) |
| Mar 2011 | - | $1.18B | $1.18B |
| Dec 2010 | $4.53B(-10.4%) | - | - |
| Dec 2009 | $5.05B | - | - |
FAQ
- What is AbbVie Inc. annual free cash flow?
- What is the all-time high annual free cash flow for AbbVie Inc.?
- What is AbbVie Inc. annual free cash flow year-on-year change?
- What is the all-time high quarterly free cash flow for AbbVie Inc.?
- What is the all-time high TTM free cash flow for AbbVie Inc.?
What is AbbVie Inc. annual free cash flow?
The current annual free cash flow of ABBV is $17.83B
What is the all-time high annual free cash flow for AbbVie Inc.?
AbbVie Inc. all-time high annual free cash flow is $24.25B
What is AbbVie Inc. annual free cash flow year-on-year change?
Over the past year, ABBV annual free cash flow has changed by -$4.23B (-19.17%)
What is the all-time high quarterly free cash flow for AbbVie Inc.?
AbbVie Inc. all-time high quarterly free cash flow is $7.72B
What is the all-time high TTM free cash flow for AbbVie Inc.?
AbbVie Inc. all-time high TTM free cash flow is $24.80B